<http://schema.org/potentialAction>
_:b1
<http://www.genengnews.com/Registration.aspx?ReturnURL=%2Fgen-news-highlights%2Fdaiichi-sankyo-licenses-phase-i-ready-cancer-drug-developed-through-arqule-partnership%2F81245935%2F>